Preview

The Evolving Finance Function: Judy C. Lewent at Merck & Co., Inc.

Good Essays
Open Document
Open Document
498 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
The Evolving Finance Function: Judy C. Lewent at Merck & Co., Inc.
Corporate Finance Assignment

The Evolving Finance Function: Judy C. Lewent at Merck & Co., Inc.

Ways in which the Financial Area at Merck added value to the company beyond its typical work: * In the 80’s era there was no systematic planning model, that’s where Merck felt the need to develop theirs, i.e., the research planning model. * They also came up with a simulation planning & hedging model, which was very effective as they kept on innovating it. * Merck had a well integrated & a centralised model which reported to a single authority. * The clients existed within the company in form of other departments. The finance department provided a wide range of financial services to them. * The forecasting & analytics department was merged with the finance department. * Recruitments in the finance department were higher than the other departments, which consisted of MBA’s from good B- schools in USA. * There was no rigidity & the finance department was constantly re-structured.

Pre-conditions that enabled Merck’s finance group to develop its capabilities: * The company was constantly rated amongst the best in the U.S.A. They had a vision to grow, which was evident from their financial figures. {Exhibit 1} * To cater to the growth they formed several alliances, in the form of Joint Ventures, which led to an increase in their market capitalisation. In order to maintain and increase their market capitalisation in the future they felt the need to come up with a model which can help them to effectively analyse the returns on their investments in future. * They faced immense competition from the local players in generic drugs and to maintain an edge over them they came up with this model. * As they focussed on innovation, they had huge R&D expenditure which kept increasing year after year. They did not have a suitable

You May Also Find These Documents Helpful

  • Good Essays

    Enabling mighty competition between commonplace drug treatments and patent-expired fashioned brands is relevant to decreasing pharmaceutical charges and stimulating innovation. However, this mentioned, there are numerous troubling problems surrounding general medicines because of the convenient access to an abundance of illegal generics on the internet breaking the patent ownership and the unregulated companies that produce and supply them. At the same time familiar medicines will have to be approved identical types of depended on drugs, providing the equal fine, safety and efficacy because the normal, that is commonly no longer the case. A conventional drug must endure strict scrutiny before it is licensed and given market approval with the aid of countrywide medicines authorities. In brief, common medicines will have to comply with the same strict standards of great, safety and efficacy as usual pharmaceutical…

    • 490 Words
    • 2 Pages
    Good Essays
  • Powerful Essays

    References: 1. Blake, Hannah. “A history of Merck & Co”. Pharmaphorum. May 30, 2013. Retrieved from http://www.pharmaphorum.com/articles/a-history-of-merck-co…

    • 1517 Words
    • 7 Pages
    Powerful Essays
  • Satisfactory Essays

    Sirtris

    • 574 Words
    • 3 Pages

    * • Partnership with Pharma. As is almost always the case in biotech, the team was in…

    • 574 Words
    • 3 Pages
    Satisfactory Essays
  • Good Essays

    Merck Stock Market Game

    • 691 Words
    • 3 Pages

    Merck (MRK) experienced only minute changes over the period that I held onto it. During this time, Merck experienced both positives and negatives, and these different experiences helped to balance the value of the company’s stock. At the beginning of the year, Merck successfully “acquired IOmet,” a company that produces “innovative medicines for the treatment of cancer.” With this new subsidiary, Merck will most likely experience an increase in profits and control over this market. Therefore, this should have helped boost the stock. However, MRK did not grow, but it remained around the same; this was probably the result of a lawsuit. The drug company’s “illegal promotion of it former painkiller Vioxx.” This 800,000,000 dollar settlement most likely negated all the small gains that MRK had made over the past weeks. With these positives and negatives MRK’s value stayed relatively constant for the last couple of…

    • 691 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    Merck/Medco Case Analysis

    • 3129 Words
    • 13 Pages

    acquisition of Medco represents a $6.6 billion bet on where the future of the pharmaceutical…

    • 3129 Words
    • 13 Pages
    Powerful Essays
  • Best Essays

    The pharmaceutical company is made up of a number of different functions and departments. Each of these functions is given a responsibility in one area of the company’s activity. These departments are closely related and the success of the company is based on the ability of these functions to work together. The pharmaceutical companies rely on research and development to find new and innovation new drugs. In order for a drug to enter the market it must undergo a series of tests and clinical trials. There are phases the drug must go through and complete in order to meet the requirements of the FDA. The development of a drug is an ongoing journey, and it can take up to 12 years to develop a drug (Pharmaceutical Patents 2006). The pharmaceutical company uses…

    • 4398 Words
    • 18 Pages
    Best Essays
  • Good Essays

    Merck's Culture

    • 435 Words
    • 2 Pages

    “May 5, 2005. It was the darkest hour in the pharmaceutical giant 's 114-year history. Merck was drowning in liability suits stemming from Vioxx, its $2.5 billion-a-year arthritis drug, which it had to pull from the market because of a link to heart attacks and strokes. Two other blockbusters worth a combined $7 billion in annual sales were facing patent expirations. And Merck 's labs, which other companies once hailed as a bastion of scientific innovation, were crippled by a culture that buried good ideas under layers of bureaucracy. But in the morass, Clark saw opportunity (www.businessweek.com).”…

    • 435 Words
    • 2 Pages
    Good Essays
  • Good Essays

    Brand and River Blindness

    • 565 Words
    • 3 Pages

    As a company that produces drugs to cure diseases in both humans and animals, Merck operates in a complex dynamic that requires it to take decisions that may not lead to profitability. Further, its corporate philosophy always revolved around the fact that the company’s first priority was the safety of people and only then did profits follow. I, therefore, believe that Merck should invest a large amount ( ~80%) of its research budget even on drugs that will produce a substandard ROI, provided the drugs promise to fully cure diseases without harmful side effects and they are the first in the market to do so. This could help them build a strong brand equity, goodwill and reputation in the long run thereby creating a foundation for profitability in future. For instance, I believe that Merck has a social responsibility and a moral obligation to invest heavily in the cure for River…

    • 565 Words
    • 3 Pages
    Good Essays
  • Good Essays

    Merck Vioxx Paper

    • 710 Words
    • 3 Pages

    Merck’s first strategy points to their good sense and knowledge of the medicine which serves to regain credibility and to establish the company as a professional organization. In the rebuttal they specifically point out Vioxx was studied both before and after getting FDA approval. By taking this approach, the company attempts to build consumer confidence and show its knowledge of their product. In addition, Merck attempts to build integrity among its employees by pointing out their policies and formal training programs.…

    • 710 Words
    • 3 Pages
    Good Essays
  • Better Essays

    Merck & Co

    • 1066 Words
    • 5 Pages

    1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop a new drug?…

    • 1066 Words
    • 5 Pages
    Better Essays
  • Powerful Essays

    Case Merck & Johnson & Johnson are two leaders producers of health care products. Each has considerable assets, and each expends considerable funds each year toward the development of new products. The development of a new health care product is often very expensive, and risky, New products frequently must undergo considerable testing before approval for distribution to the public. For example, it took Johnson & Johnson 4 years and $200 million to develop its 1 Day ACUVUE contact lenses. Below are some basic data complied from the financial statements of these two companies.…

    • 881 Words
    • 4 Pages
    Powerful Essays
  • Powerful Essays

    Pricing pressures from managed care and government programs and the migration to generic drugs due to a large number of patent expirations plagued pharmaceutical companies…

    • 1783 Words
    • 8 Pages
    Powerful Essays
  • Good Essays

    Merck was renowned for its research labs which had decades of achievements, turning out one innovation after another, including drugs for tuberculosis, cholesterol, hypertension, and AIDS. In the early 2000s Merck spent around 3 billion in research; some felt that the company culture was shaped by its research agenda. The company was described as “intense, driven, loyal, scientifically brilliant, collegial, and arrogant”…

    • 2172 Words
    • 7 Pages
    Good Essays
  • Good Essays

    Merck Case

    • 587 Words
    • 4 Pages

    1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop drugs?…

    • 587 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    scale, the company was able to sell generic products 20 to 75 percent cheaper than its branded…

    • 6683 Words
    • 27 Pages
    Powerful Essays